Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.20.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Accumulated amortization of deferred leasing costs $ 31,927 $ 33,782
Investing receivable allowance for credit loss $ 4,040  
Common Shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common Shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common Shares of beneficial interest issued (in shares) 112,175,688 112,068,705
Common Shares/units of beneficial interest, shares outstanding (in shares/units) 112,175,688 112,068,705
Corporate Office Properties, L.P.    
Accumulated amortization of deferred leasing costs $ 31,927 $ 33,782
Investing receivable allowance for credit loss $ 4,040  
Corporate Office Properties, L.P. | General Partner    
Common Shares/units of beneficial interest, shares outstanding (in shares/units) 112,175,688 112,068,705
Corporate Office Properties, L.P. | Limited Partner    
Common Shares/units of beneficial interest, shares outstanding (in shares/units) 1,628,421 1,482,425
Preferred units (in units) 352,000 352,000
Investing Receivables    
Investing receivable allowance for credit loss $ 4,040 $ 0